Clinical trial
Predicting Outcome in Cervix Carcinoma: a Prospective Study
NCT01825005 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predicting Outcome in Cervix Carcinoma: a Prospective Study
- Lead sponsor
- Maastricht Radiation Oncology
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- August 31, 2018
- Enrollment
- 423 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer